ASCO 2022 Updates in HR+/HER2- eBC
ASCO 2022 on the Adjuvant Endocrine Therapy for ER+/HER2- Breast Cancer
By
ecancer
FEATURING
Etienne Brain
By
ecancer
FEATURING
Etienne Brain
Login to view comments.
Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC